SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001457612-20-000170
Filing Date
2020-10-29
Accepted
2020-10-29 16:00:52
Documents
64
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gnca-20200930.htm   iXBRL 10-Q 1196539
2 EX-31.1 gnca-ex31120200930x10q.htm EX-31.1 12268
3 EX-31.2 gnca-ex31220200930x10q.htm EX-31.2 11938
4 EX-32.1 gnca-ex32120200930x10q.htm EX-32.1 7866
5 EX-32.2 gnca-ex32220200930x10q.htm EX-32.2 7750
11 gnca-20200930_g1.jpg GRAPHIC 16581
  Complete submission text file 0001457612-20-000170.txt   5809461

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20200930.xsd EX-101.SCH 40309
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gnca-20200930_cal.xml EX-101.CAL 76137
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnca-20200930_def.xml EX-101.DEF 220316
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20200930_lab.xml EX-101.LAB 511432
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20200930_pre.xml EX-101.PRE 351042
12 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20200930_htm.xml XML 953639
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36289 | Film No.: 201272576
SIC: 2836 Biological Products, (No Diagnostic Substances)